Pakistan – After WHO Acceptance, Pakistan Drafts Pharmacovigilance Guidelines

The Drug Regulatory Authority of Pakistan (DRAP) has published draft pharmacovigilance guidelines. The document provides a basic framework for pharmacovigilance in an attempt to operationalize the monitoring of drug safety in Pakistan.

Pharmacovigilance practices are less well-established in Pakistan than in many other parts of the world. Last year, Pakistan became the 134th full member of the World Health Organization (WHO) Programme for International Drug Monitoring (PIDM). Countries including Liberia, Niger and Sudan joined WHO-PIDM before Pakistan…